Divis Laboratories Fact Sheet, Divis Laboratories Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Divis Laboratories Fact Sheet    (DIVI)


Find Out: How to Create Massive Gains from Govt's Mega 2023 Plan?


Here is the latest financial fact sheet of Divis Laboratories. For more details, see the Divis Laboratories quarterly results and Divis Laboratories share price and chart. For a sector overview, read our pharmaceuticals sector report.

DIVIS LABORATORIES Price History

Price Rs 5,130.0
Mkt Cap Rs m 1,361,854
Vol '000 147.2
P/E X 66.5
P/CF X 60.8
EPS (TTM) Rs 77.2
% ch % -1.2
No. of shares m 265.47
% ch week % -0.3
% ch 1-mth % 0.4
% ch 12-mth % 65.9
52 week H/L Rs 5,425.0/3,015.0
(As on Oct 20, 2021 03:35:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DIVIS LABORATORIES Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
DIVIS LABORATORIES EQUITY SHARE DATA
High Rs1,3801,1421,7672,2583,913 
Low Rs6125339951,4671,824 
Sales per share (Unadj.) Rs151.5145.8186.3203.2262.5 
Earnings per share (Unadj.) Rs39.933.051.051.974.7 
Diluted earnings per shareRs39.933.051.051.974.7 
Cash flow per share (Unadj.) Rs44.638.457.358.984.4 
Dividends per share (Unadj.) Rs10.0010.0016.0016.0020.00 
Adj. dividends per shareRs10.0010.0016.0016.0020.00 
Avg Dividend yield %1.01.21.20.90.7 
Book value per share (Unadj.) Rs201.8223.2262.1275.4350.1 
Adj. book value per shareRs201.8223.2262.1275.4350.1 
Shares outstanding (eoy) m265.47265.47265.47265.47265.47 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x6.65.77.49.210.9 
Avg P/E ratio x24.925.327.135.938.4 
P/CF ratio (eoy) x22.321.824.131.634.0 
Price / Book Value ratio x4.93.85.36.88.2 
Dividend payout %25.030.331.430.926.8 
Avg Mkt Cap Rs m264,354222,310366,619494,429761,517 
No. of employees `000NANANANANA 
Total wages/salary Rs m4,9994,5615,4236,2118,258 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
DIVIS LABORATORIES INCOME DATA
Net Sales Rs m40,22438,70249,46353,94469,694 
Other income Rs m7491,1341,5561,896626 
Total revenues Rs m40,97339,83651,01955,84170,320 
Gross profit Rs m14,47112,62818,73018,23228,612 
Depreciation Rs m1,2331,4251,6891,8622,556 
Interest Rs m3424477121 
Profit before tax Rs m13,95312,31318,55118,19526,660 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m3,3493,5435,0234,4296,818 
Profit after tax Rs m10,6048,77013,52713,76519,843 
Gross profit margin %36.032.637.933.841.1 
Effective tax rate %24.028.827.124.325.6 
Net profit margin %26.422.727.325.528.5 
DIVIS LABORATORIES BALANCE SHEET DATA
Current assets Rs m40,10545,35146,50155,73567,906 
Current liabilities Rs m6,5956,5348,46818,20517,284 
Net working cap to sales %83.3100.376.969.672.6 
Current ratio x6.16.95.53.13.9 
Inventory Days Days2763382197610 
Debtors Days Days829686956878 
Net fixed assets Rs m34,18138,12041,45238,51545,963 
Share capital Rs m531531531531531 
"Free" reserves Rs m53,04358,71769,04172,56892,415 
Net worth Rs m53,57459,24869,57273,09992,946 
Long term debt Rs m00000 
Total assets Rs m74,28683,47187,95394,250113,869 
Interest coverage x416.3520.5397.4255.81,270.5 
Debt to equity ratio x00000 
Sales to assets ratio x0.50.50.60.60.6 
Return on assets %14.310.515.414.717.4 
Return on equity %19.814.819.418.821.3 
Return on capital %26.120.826.725.028.7 
Exports to sales %00000 
Imports to sales %25.521.924.621.50 
Exports (fob) Rs m00000 
Imports (cif) Rs m10,2608,48512,18711,5970 
Fx inflow Rs m35,38432,35941,23844,8320 
Fx outflow Rs m10,2739,04212,40511,8370 
Net fx Rs m25,11123,31728,83332,9960 
DIVIS LABORATORIES CASH FLOW
From Operations Rs m 11,504 7,759 9,543 12,159 19,469 
From Investments Rs m -11,396 -4,783 -6,854 -835 751 
From Financial Activity Rs m 24 -3,142 -2,459 -10,914 -349 
Net Cashflow Rs m 132 -166 230 411 19,872 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 52.0%
Institution 37.1%
Non-Institution 11.0%
Total 100.0%
Free Float 48.1%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF 1-72/23( P)/ Divis/303, Divi Towers Cyber Hills, Gachibowli, Hyderabad - 500032
E-MAIL mail@divislabs.com WEB www.divislabs.com
TEL 040 2378 6300 FAX 040 2378 6460
SECTOR PHARMACEUTICALS GROUP Divis Labs
TR AGENT K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
AUDITOR P. V. R. K. Nageswara Rao & Co.
CHM: Murali K. Divi (MD) COMP SEC: P. V. Lakshmi Rajani YEAR OF INC: 1990 BSE CODE: 532488 FV (Rs): 2 DIV YIELD (%): 0.4

Read: DIVIS LABORATORIES 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   BH.IMMUN&BIO  ANUH PHARMA  SWAGRUHA INFRA  DESH RAKSHAK  AMBALAL SARABHAI  

Compare DIVIS LABORATORIES With:   BH.IMMUN&BIO  ANUH PHARMA  SWAGRUHA INFRA  DESH RAKSHAK  AMBALAL SARABHAI  




Today's Market

Sensex Trades Marginally Lower, Dow Futures Down by 30 Points(12:30 pm)

Share markets in India are presently trading marginally lower. The BSE Sensex is trading down by 226 points, down 0.4%, at 62,489 levels.

Views on news

DIVIS LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Aug 12, 2021 | Updated on Aug 12, 2021

Here's an analysis of the annual report of DIVIS LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.2% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, DIVIS LABORATORIES has posted a net profit of Rs 6 bn (up 13.2% YoY). Sales on the other hand came in at Rs 20 bn (up 13.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY21); Net Profit Up 29.3% (Quarterly Result Update)

Jun 28, 2021 | Updated on Jun 28, 2021

For the quarter ended March 2021, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 29.3% YoY). Sales on the other hand came in at Rs 18 bn (up 28.7% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

5 Exciting 'Unlisted' Companies and How to Play Them (Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

Modi's Big Move Could Boost these 5 Defence Stocks (Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - ADCOCK INGRAM COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS